Partnership expands access to men’s health treatment
News
Orpathys plus Tagrisso shows survival benefit in lung cancer
Saffron trial delivers positive results
Definium reports positive results for anxiety treatment
Phase 3 study shows strong efficacy
Veppanu launch brings new option for advanced breast cancer
Rigel makes Veppanu available across US
First patient treated in new heavy‑chain‑only antibody trial
Study begins testing KJ‑103 in TROP2‑positive cancers
Novo Nordisk and AWS form AI partnership to speed drug discovery
New alliance aims to accelerate development of future medicines
Kupando doses first patient in phase 1 trial
KUP101 enters clinic for advanced solid tumours
First-in-class house dust mite allergy treatment now available in Scotland
SMC acceptance offers new option for patients
NHS backs new treatment option for cystinosis
Delayed‑release mercaptamine approved for routine use
Fridge‑free vaccine shows global potential
Stablepharma’s thermostable td shot delivers strong phase 1 data
Lexeo wins FDA RMAT status for LX2020
Regulator backs gene therapy for PKP2-ACM
EHP Awards 2027 open for entries
Programme celebrates partnership excellence
NICE backs new blood cancer regimens
Acalabrutinib combinations approved for CLL and MCL
Obsidian begins registration cohort for amsoki-cel
First patient enrolled in Agni-01 expansion
Entera Bio data selected for ASBMR plenary session
Postmenopausal study highlights oral anabolic potential
